Inhibition activity of semenogelin and its peptides to human spermatozoa.
- Author:
Zeng-jun WANG
1
;
Wei ZHANG
;
Hong-fei WU
;
Yuan-geng XU
Author Information
- Publication Type:Journal Article
- MeSH: Cloning, Molecular; Dose-Response Relationship, Drug; Escherichia coli; genetics; Humans; Recombinant Proteins; biosynthesis; pharmacology; Seminal Vesicle Secretory Proteins; biosynthesis; genetics; pharmacology; Sperm Motility; drug effects
- From: National Journal of Andrology 2007;13(1):42-45
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the inhibition activity of Semenogelin (Sg) and its different peptides to human spermatozoa.
METHODSHuman Sg DNA and its N-terminal Sg and C-terminal Sg DNA were cloned into PET-100 vector. Positive colonies were screened and transformed into E. Coli BL21 (DE3). Recombinant Sg and its peptides were induced and expressed in high competent E. coli BL21 (DE3) , and purified by 50% Ni-NTA column. Inhibition activity assay was done by adding 4 different concentrations of semenogelin and its two peptides, 0, 1, 5 and 10 ng/microl, to human spermatozoa.
RESULTSThe peptide of Semenogelin that inhibits the activity of human spermatozoa was located in its N-terminal fragment. C-terminal Sg did not inhibit the activity of spermatozoa.
CONCLUSIONN-terminal Sg is the inhibition peptide of the whole molecular Sg. During semen liquefaction, this peptide should be cut off from the surface of human spermatozoa before they move forward.
